Immunosuppression, IBD, and risk of lymphoma

被引：4
作者：
Bebb, JR [1 ]
Aithal, GP [1 ]
Logan, RPH [1 ]
机构：
[1] Univ Nottingham Hosp, Div Gastroenterol, Nottingham NG7 2UH, England
来源：
GUT | 2002年 / 51卷 / 02期
关键词：
D O I：
10.1136/gut.51.2.296
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：296 / 296
页数：1
相关论文
共 6 条
[1]   Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment [J].
Aithal, GP ;
Mansfield, JC .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (08) :1101-1108
[2]   Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma? [J].
Bebb, JR ;
Logan, RPH .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) :1843-1849
[3]   INCIDENCE OF CANCER IN RHEUMATOID-ARTHRITIS AND OTHER DISORDERS AFTER IMMUNOSUPPRESSIVE TREATMENT [J].
KINLEN, LJ .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (1A) :44-49
[4]   Azathioprine for maintenance of remission in Crohn's disease: Benefits outweigh the risk of lymphoma [J].
Lewis, JD ;
Schwartz, JS ;
Lichtenstein, GR .
GASTROENTEROLOGY, 2000, 118 (06) :1018-1024
[5]   INCIDENCE OF NON-HODGKIN-LYMPHOMA IN KIDNEY AND HEART-TRANSPLANT RECIPIENTS [J].
OPELZ, G ;
HENDERSON, R .
LANCET, 1993, 342 (8886-7) :1514-1516
[6]  
1987, IARC SCI PUBL, V88
1